GamePlan Medical

Physician specialists in multi-condition rehabilitation creating individualized self-management care plans.

Website: https://gameplanmedical.com/

Cover Block

PUBLIC

Field Value
Name GamePlan Medical
Tagline Physician specialists in multi-condition rehabilitation creating individualized self-management care plans
Headquarters Charlotte, North Carolina, United States
Founded 2023
Business Model B2C
Industry Healthtech (physiatry / rehabilitation)
Technology Type Software (Non-AI)
Geography North America

Links

PUBLIC

Executive Summary

PUBLIC

GamePlan Medical is a Charlotte-based healthtech company founded in 2023 that positions its clinicians as the only physician specialists trained in multi-condition rehabilitation, packaging that expertise into individualized self-management care plans delivered through a coaching app [GamePlan Medical]. The company's pitch sits at the intersection of physiatry (physical medicine and rehabilitation) and digital coaching, a niche that has historically been served either by in-person rehab clinics or by single-condition digital therapeutics. Its differentiation, as described on its own properties, is breadth: care plans intended to improve strength, function, and resilience for patients regardless of age or underlying condition, with independent pharmacies framed as a distribution and support layer [X (Twitter), July 2025]. The technology asset is described as an app built by physiatrists to function as a Functional Personal Training platform, used by the Health Gameplan team for at-home coaching [GamePlan Medical]. No funding rounds, institutional investors, customer counts, or revenue figures have been disclosed in public sources reviewed for this report, which is consistent with a company in its first two years of operation. Over the next 12 to 18 months, the items worth watching are whether GamePlan Medical formalizes a payer or pharmacy-network partnership, whether it discloses outside capital, and whether the executive team adds operators with prior healthtech commercialization experience.

Data Accuracy: YELLOW -- Confirmed by GamePlan Medical's own properties and a July 2025 X profile; no third-party press, database listing, or funding record corroborates the team or traction picture.

Taxonomy Snapshot

Axis Value
Business Model B2C (with possible pharmacy channel)
Industry / Vertical Healthtech, physiatry and rehabilitation
Technology Type Software (Non-AI), mobile coaching app
Geography North America (HQ Charlotte, NC)

Company Overview

PUBLIC

GamePlan Medical was established in 2023 and operates from Charlotte, North Carolina [GamePlan Medical]. The company describes itself across two web properties, gameplanmedical.com and healthgameplan.org, and presents Health Gameplan as the clinical service arm offering an interprofessional, collaborative approach to patient care that is meant to give patients a comprehensive support team and an active role in self-management of their health [GamePlan Medical].

The public narrative positions the company within physiatry, the medical specialty focused on physical medicine and rehabilitation, but extends the scope from single-injury or single-diagnosis rehab toward what the company calls multi-condition rehabilitation. Its July 2025 social presence frames the model as a next-generation sub-specialty that pairs physiatrists with independent pharmacies as the self-management support team for patients [X (Twitter), July 2025]. Pharmacy involvement, if it materializes into formal contracts, would be a notable structural choice because it implies a community-anchored distribution layer rather than a direct-to-consumer subscription funnel.

Milestones in the public record are sparse: company formation in 2023, the launch of the coaching app described on the technology page, and the establishment of an X account in July 2025 [X (Twitter), July 2025]. No fundraising, regulatory clearance, clinical study, or named enterprise customer has surfaced in the sources reviewed.

Data Accuracy: YELLOW -- Founding year and HQ confirmed by GamePlan Medical's own pages and X profile; no independent registry filing was located in this pass.

Product and Technology

MIXED

The core product is a mobile coaching app described on the company's technology page as built by physiatrists with the goal of improving functional capacity and creating a Functional Personal Training platform [GamePlan Medical]. The Health Gameplan clinical team is positioned as the human layer on top of the app, using it as a coaching surface to support patients at home [GamePlan Medical]. Two specific care frameworks are referenced on the secondary site: a Brain Care Score program and an ILF / ALF (independent living facility / assisted living facility) workflow, suggesting the company is targeting older adults and cognitive-plus-functional decline as priority use cases [GamePlan Medical].

The stack itself is not publicly documented. There is no GitHub organization linked from the company website, no App Store or Google Play listing surfaced in the research pass, and no engineering job postings to infer infrastructure from. Because the app does not appear to be discoverable through major consumer app stores at the time of this review, distribution likely runs through clinician onboarding rather than direct consumer download, though that is an inference rather than a confirmed go-to-market.

For a venture in its second year, the product surface is plausible but lightly evidenced. The most useful disclosures would be the regulatory posture of the app (wellness tool versus FDA-regulated software as a medical device), any outcomes data from the Brain Care Score or ILF/ALF programs, and the contractual relationship between Health Gameplan clinicians and the app entity.

Data Accuracy: ORANGE -- Product descriptions rely on the company's own website with no independent demo, app-store listing, or third-party review located.

Market Research and Opportunity

PUBLIC

The market matters now because the population GamePlan Medical targets, older adults with multiple chronic conditions and functional decline, is the single largest cost center in U.S. healthcare and the one most exposed to home-based care reimbursement reforms.

GamePlan Medical sits in the intersection of three adjacent markets that have all attracted institutional capital over the last five years: digital musculoskeletal (MSK) care, remote therapeutic monitoring (RTM) under CMS reimbursement codes introduced in 2022, and the broader category of digital therapeutics for chronic-condition self-management. None of these markets has been sized in a third-party report cited in the research pass for GamePlan Medical specifically, so any TAM number here would be analogous rather than direct. As an analogous reference, Hinge Health (digital MSK) and Sword Health (digital MSK and pelvic health) have both been valued in the multi-billion-dollar range in private rounds reported by general business press, which establishes that investors will underwrite large outcomes in adjacent niches; whether physiatrist-led multi-condition rehab is a comparable category is the open question.

Demand drivers that the cited material implicitly leans on include the demographic shift toward an older U.S. population, the policy push to move post-acute and rehabilitation care out of skilled nursing facilities and into the home, and the reimbursement opening created by RTM codes, which allow remote collection of non-physiologic data such as adherence and functional status. The independent-pharmacy distribution angle that the company surfaces on X is itself a tailwind story: independent pharmacies have been searching for clinical service revenue beyond dispensing margins, and a self-management coaching contract is one possible answer [X (Twitter), July 2025].

Key adjacent and substitute markets include in-person outpatient physical therapy (the established standard of care, reimbursed by Medicare and commercial payers), single-condition digital therapeutics (typically narrower in scope but with stronger clinical evidence packages), and care-management overlays sold by payers and Medicare Advantage plans directly to their members. Regulatory forces to watch are the FDA's evolving posture on software-based wellness versus medical-device classification, and any CMS rulemaking that expands or narrows RTM and chronic care management codes.

Sizing reference Value Source
Analogous category: digital MSK private valuations Multi-billion (private rounds, peers) General business press, analogous market

The analyst takeaway is that the category around GamePlan Medical is real and well-funded at the edges, but the company has not yet published the kind of sizing or outcomes data that would let an investor underwrite a specific share of that opportunity.

Data Accuracy: ORANGE -- No third-party market sizing was captured for GamePlan Medical's specific segment; references above are analogous categories noted for context.

Competitive Landscape

MIXED

GamePlan Medical is positioned as a physiatrist-led, multi-condition coaching service in a market where the loudest competitors are single-condition digital therapeutics and in-person outpatient rehab.

The competitive map can be drawn in three bands. The first band is incumbents: hospital-affiliated outpatient physical therapy clinics and skilled nursing facility rehab programs, which own the relationship with the post-acute patient today and bill Medicare directly. They are slow to digitize but hold the referral pipeline from physicians and discharge planners. The second band is digital-first challengers in adjacent niches, most visibly digital MSK companies that have raised large private rounds and built employer and health-plan distribution; these companies are usually narrower in clinical scope than GamePlan Medical describes itself to be (focused on back, knee, shoulder rather than multi-condition function and resilience), but they have far more capital, brand, and outcomes data. The third band is care-management overlays sold by Medicare Advantage plans and ACO enablers, which can absorb a self-management coaching workflow into an existing covered-life contract.

GamePlan Medical's defensible edge today, if any, is clinical positioning: physiatrists are a relatively scarce specialty, and a service that genuinely combines physiatrist oversight with at-home coaching across multiple conditions is a real differentiation against single-condition apps. The independent-pharmacy distribution angle [X (Twitter), July 2025] is a second potential edge, because it routes around the crowded employer-benefits channel that digital MSK companies fight over. Both edges are perishable: the physiatrist labor pool is small, which is a constraint as much as a moat, and pharmacy partnerships are non-exclusive by default unless the company signs structured agreements.

The most exposed flank is evidence and distribution scale. Without published outcomes data, payer contracts, or a named enterprise customer, GamePlan Medical cannot yet meet the procurement bar that self-insured employers and Medicare Advantage plans apply to digital health vendors, which is the channel where the well-capitalized competitors are already entrenched. The most plausible 18-month scenario is a bifurcation: GamePlan Medical wins if it lands a structured contract with a regional pharmacy chain or a Medicare Advantage plan in the Carolinas and uses that to publish functional-outcomes data; it loses ground if a digital MSK incumbent extends its clinical scope into multi-condition coaching first, since that competitor would arrive with existing covered-life distribution.

Opportunity

PUBLIC

The size of the prize, if GamePlan Medical executes, is to become the default physiatrist-led self-management layer for older adults aging in place, a population that is the largest single cost driver in U.S. healthcare.

The headline opportunity. The plain-language outcome GamePlan Medical could plausibly become is the clinical operating system for community-based multi-condition rehabilitation: a service that sits between the primary care physician, the independent pharmacy, and the patient's home, and that owns the functional-status data trail that payers increasingly need to administer value-based contracts. The cited evidence that makes this reachable rather than aspirational is narrow but specific: the company has chosen a sub-specialty (physiatry) where there are very few digital-first national brands, and it has publicly framed independent pharmacies as a structural distribution partner rather than a marketing afterthought [X (Twitter), July 2025]. If even one regional pharmacy network signs on, the company has a repeatable template that none of the digital MSK incumbents are currently pursuing.

Growth scenarios.

Scenario What happens Catalyst Why it's plausible
Pharmacy channel build-out GamePlan Medical signs a regional independent-pharmacy network as a self-management support partner and bills under existing remote therapeutic monitoring codes A signed contract with a Carolinas-area pharmacy cooperative Company has publicly framed pharmacies as the support team [X (Twitter), July 2025]
ILF / ALF embedded service The Health Gameplan team becomes the contracted rehabilitation and functional-coaching layer for independent and assisted living facilities A multi-facility operator agreement Company already publishes an ILF / ALF program page [GamePlan Medical]
Brain Care Score wedge The Brain Care Score program becomes a recognized cognitive-plus-functional screening tool referenced by primary care A peer-reviewed publication or payer adoption Company has built and published the program framework [GamePlan Medical]

What compounding looks like. The flywheel, if it starts turning, is data and referral concentration. Every patient enrolled through a pharmacy or ILF/ALF partner generates functional-status and adherence data that, in aggregate, becomes the evidence package the company needs to sign the next, larger partner. Physiatrist time is the constraint, so the unit economics improve only if the coaching app meaningfully extends each clinician's panel size; that is the operational assumption the entire model rests on. There is no public evidence yet that the flywheel is turning, but the structural pieces (a clinical service arm, an app, and a stated channel partner type) are in place.

The size of the win. As a scenario, not a forecast: digital MSK peers in adjacent categories have been valued in the multi-billion-dollar range in private rounds reported by general business press, which establishes a credible upper bound for what a digital-first physiatry platform with payer contracts could be worth. GamePlan Medical is many steps from that comparison, and the relevant near-term milestones are a first disclosed funding round, a first named pharmacy or facility partner, and a first published outcomes dataset. Each of those would meaningfully tighten the range of plausible outcomes.

Data Accuracy: YELLOW -- Scenarios are grounded in the company's own published programs and channel framing; valuation comparisons are explicitly analogous and not direct.

Sources

PUBLIC

  1. [GamePlan Medical] GamePlan Medical homepage | https://gameplanmedical.com/

  2. [X (Twitter), July 2025] Gameplan Medical (@gameplanmedical) profile | https://x.com/gameplanmedical

  3. [GamePlan Medical] Our Technology page | https://healthgameplan.org/our-technology/

  4. [GamePlan Medical] Our Executive Team page (healthgameplan.org) | https://healthgameplan.org/our-executive-team/

  5. [GamePlan Medical] Our Executive Team page (gameplanmedical.com) | https://gameplanmedical.com/our-executive-team/

  6. [GamePlan Medical] Brain Care Score program page | https://healthgameplan.org/brain-care-score/

  7. [GamePlan Medical] ILF / ALF program page | https://healthgameplan.org/ilf-alf/

  8. [LinkedIn] Dr Andy McDonald, CEO and Co-Founder profile | https://www.linkedin.com/in/andymcdonaldpt/

  9. [LinkedIn] Lukas Holderried, Co-Founder profile | https://de.linkedin.com/in/lukas-holderried-3a6755150

Articles about GamePlan Medical

View on Startuply.vc